Kateryna Gashynova
← Back to Dnipro State Medical University
Dnipro State Medical University
Kateryna Gashynova works in Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Cystic Fibrosis Research Advances, COVID-19 Clinical Research Studies, Inhalation and Respiratory Drug Delivery. Recorded institutional associations include University of Freiburg, University Medical Center Freiburg, Dnipro State Medical University.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Bronchoectatic disease: the state of art and the clinical case.
2018 · 6 citationsInvasive pulmonary aspergillosis: the state of art and the clinical case.
2018 · 4 citationsThe structure of industrially predisposed diseases in workers of the metallurgical enterprise working in harmful conditions.
2018 · 4 citationsMicrobiome landscape and disease duration role in allergy in adult patients with bronchiectasis
2019 · 4 citationsSYSTEMIC EFFECTS AND COMORBIDITY IN OUTPATIENTS WITH COPD
2013 · 3 citationsAssessment of senior medical students’ knowledge in treatment of patients with community-acquired pneumonia (KNOCAP project)
2017 · 3 citationsChronic obstructive pulmonary disease (COPD): influence of clinic-anamnestic, anthropometric and functional characteristics on serum α-1-anitrypsin (AAT) in stable patients.
2018 · 3 citationsFACTORS AFFECTING THE FREQUENCY OF EXACERBATIONS IN ADULT PATIENTS WITH BRONCHIECTASIS
2020 · 3 citationsAllergic bronchopulmonary aspergillosis: XXI century. A modern view on the problem
2018 · 2 citationsMatrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis
2019 · 2 citationsPeripheral blood eosinophilia and sensitization to Aspergillus fumigatus in adult patients (pts) with non-cystic fibrosis bronchiectasis (B)
2019 · 2 citationsApplication of erdosteine in the treatment of occupational chronic obstructive pulmonary disease
2019 · 2 citationsERS International Congress 2020: highlights from the Respiratory Infections assembly
2021 · 2 citationsRate of respiratory symptoms in naïve patients with Chronic lymphocytic leukemia
2020 · 2 citationsPulmonary comorbidity in chronic lymphoproliferative diseases: realities of the problem in the Dnipro region
2021 · 2 citationsPathogenetic treatment of patients with COVID-19 at the outpatient stage
2022 · 2 citationsCLINICAL AND LABORATORY FEATURES OF CORONAVIRUS DISEASE AND RISK FACTORS OF LETHAL OUTCOME IN PATIENTS WHO REQUIRED HOSPITALIZATION DURING THE THIRD WAVE OF COVID-19 IN UKRAINE: A SINGLE-CENTER RETROSPECTIVE STUDY
2022 · 2 citationsCOPD: Plasma surfactant protein-D (SPD) concentration as a predictor of acute exacerbations (AE) probability
2016 · 1 citationsAssessment of senior medical students in the field of COPD (ASCO project). Update 2016
2017 · 1 citationsAlgorithm of creating an educational video film from the cycle “Clinical immunology and allergology”
2018 · 1 citationsCHARACTERISTICS OF ARTICULAR SYNDROME IN SYSTEMIC VASCULITIS.
2017 · 1 citationsLSC - 2019 - Plasma surfactant protein-D (SP-D) as a predictor of COPD severe acute exacerbation (SAE)
2019 · 1 citationsOVERWEIGHT PATIENTS WITH BRONCHIECTASIS: DOES IT MATTER FOR SPUTUM CULTURE?
2020 · 1 citationsLSC - 2020 - Could the overweight influence bronchiectasis (B) exacerbations frequency (EF)?
2020 · 1 citationsCondition of cellular immunity in patients with prolonged course of community acquired pneumonia
2020 · 1 citations
